Skip to main navigation Skip to search Skip to main content

Report of a ‘consensus’ on the lines of therapy for primary immune thrombocytopenia in adults, promoted by the Italian Gruppo di Studio delle Piastrine

  • Lorenzo Cirasino
  • , Anna M. Robino
  • , Gian Marco Podda
  • , Emmanuel Andrès
  • , Jenny M. Despotovic
  • , Mohsen Elalfy
  • , Andreas Holbro
  • , Tadakazu Kondo
  • , Michele P. Lambert
  • , Sandra R. Loggetto
  • , Keith R. McCrae
  • , Jong Wook Lee
  • , Marco Cattaneo
  • Ospedale di Ostuni
  • Asst Grande Ospedale Metropolitano Niguarda
  • University of Milan
  • Department of Sleep Medicine, Strasbourg University Hospital, Strasbourg University
  • Texas Children’s Hematology Center
  • Ain Shams University
  • University of Basel
  • Kyoto University
  • University of Pennsylvania
  • Sabara Pediatric Hospital
  • Cleveland Clinic Lerner College of Medicine of Case Western Reserve University

Research output: Contribution to journalReview articlepeer-review

2 Scopus citations

Abstract

Despite the publication in 2009 of a paper on ‘terms and definitions of immune thrombocytopenia’ (ITP), some unresolved issues remain and are reflected by the disagreement in the treatment suggested for primary ITP in adults. Considering that these disagreements could be ascribed to non-shared goals, we generated a ‘consensus’ on some terms, definitions, and assertions useful for classifying the different lines of treatment for primary ITP in adults according to their indications and goals. Agreement on the appropriateness of the single assertions was obtained by consensus for the following indicators: 1. classification of four ‘lines of therapy’; 2. acceptance of the expression ‘sequences of disease’ for the indications of the respective four lines of treatment; 3I. practicability of splenectomy; 3Ib. acceptance, with only some exceptions, of a ‘timing for elective splenectomy of 12 months’; and 4a-d. ‘goals of the four lines of therapy.’ On the basis of the consensus, a classification of four lines of treatment for primary ITP in adults was produced. In our opinion, this classification, whose validity is not influenced by the recently published new guidelines of the American Society of Hematology (ASH) and reviews, could reduce the disagreement that still exists regarding the treatment of the disease.

Original languageEnglish
Pages (from-to)461-473
Number of pages13
JournalPlatelets
Volume31
Issue number4
DOIs
StatePublished - 18 May 2020

Bibliographical note

Publisher Copyright:
© 2020, © 2020 Taylor & Francis Group, LLC.

Keywords

  • Classification
  • ITP
  • consensus
  • goal
  • immune thrombocytopenia
  • therapy

Fingerprint

Dive into the research topics of 'Report of a ‘consensus’ on the lines of therapy for primary immune thrombocytopenia in adults, promoted by the Italian Gruppo di Studio delle Piastrine'. Together they form a unique fingerprint.

Cite this